Literature DB >> 26965808

Predictors of Severity in Diabetic Foot Infections.

Devon Callahan1, Jessica Keeley1, Hamid Alipour1, Christian DeVirgilio1, Amy Kaji1, David Plurad1, Dennis Y Kim2.   

Abstract

BACKGROUND: Diabetic foot infections (DFIs) constitute a large burden of the morbidity of diabetes, with more than 70,000 lower-extremity amputations (LEA) performed annually in the United States. A necrotizing infection signifies the most severe form of infection and is a key factor in the decision to proceed to LEA for source control. Key clinical and laboratory variables can assist in the identification of necrotizing infections; however, the effect of diabetes on these variables is unknown. Given the increased level and complexity of metabolic derangements in diabetic patients, we sought to examine characteristics predictive of necrotizing infection in patients with DFI who underwent LEA.
METHODS: We performed a single-institutional retrospective analysis of diabetic patients who underwent a LEA for DFIs over an 18-month period. Patients with necrotizing infection on final pathology were compared with patients without this pathologic finding. Multivariate analysis was performed to identify independent predictors of necrotizing infection.
RESULTS: Of 183 patients, 57 (31%) had evidence of necrotizing infections. Factors associated with necrotizing infection on univariate analysis were the presence of bullae (11% vs. 2%; odds ratio [OR] = 4.8, P = 0.03), a higher mean admission white blood cell count (WBC; 15 vs. 12, P = 0.002), a lower mean absolute sodium (132 vs. 134, P = 0.01), a higher hemoglobin A1C (11.3 vs. 10.3, P = 0.05), hyperglycemia (289 vs. 248, P = 0.04), elevated C-reactive protein (20 vs. 11, P = 0.02), and the presence of Pseudomonas aeruginosa on final tissue culture (12.3 vs. 1.6, P = 0.004). These patients were taken to surgery more rapidly (22.5 vs. 31 hr, P = 0.04), and they had a longer postoperative stay (7 vs. 4 days, P = 0.02). On multivariate analysis, an elevated WBC was predictive of necrotizing infection (OR = 1.1, P = 0.01), whereas alcohol use was found to be protective (OR = 0.3, P = 0.04).
CONCLUSIONS: Clinical and laboratory variables known to be associated with necrotizing infections among the general population appear to be predictive of disease severity among patients undergoing amputation for DFIs. Identification of these abnormalities preoperatively may allow for improved operative planning, shared decision making, and resource management. Prospective validation of these findings is potentially warranted.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26965808     DOI: 10.1016/j.avsg.2016.01.003

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  5 in total

1.  The role of the platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in the prediction of length and cost of hospital stay in patients with infected diabetic foot ulcers: A retrospective comparative study.

Authors:  Mehmet Ali Eren; Ali Erdal Güneş; İdris Kırhan; Tevfik Sabuncu
Journal:  Acta Orthop Traumatol Turc       Date:  2020-03       Impact factor: 1.511

2.  Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation.

Authors:  Xueyao Yin; WeiFen Zhu; Chao Liu; Huilan Yao; Jiaxing You; Yixin Chen; Xiaofang Ying; Lin Li
Journal:  Ther Adv Endocrinol Metab       Date:  2022-05-18       Impact factor: 4.435

3.  Long non-coding RNA Lethe regulates hyperglycemia-induced reactive oxygen species production in macrophages.

Authors:  Carlos Zgheib; Maggie M Hodges; Junyi Hu; Kenneth W Liechty; Junwang Xu
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

4.  Therapeutic effects of moxibustion simultaneously targeting Nrf2 and NF-κB in diabetic peripheral neuropathy.

Authors:  Jia Li; Xia Hu; Fengxia Liang; Jianmin Liu; Huanjiao Zhou; Jiaoping Liu; Hua Wang; Hongtu Tang
Journal:  Appl Biochem Biotechnol       Date:  2019-06-17       Impact factor: 2.926

5.  Clinical Study of MEBO Combined with Jinhuang Powder for Diabetic Foot with Infection.

Authors:  Hong-Bo Zhan; Qing-Qing Sun; Lei Yan; Jia Cai
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-13       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.